glp-1 agonists blindness risk GLP 1 Doctor Explains GLP 1 Blindness
Description
Drug designers are creating multi-agonists that stimulate more than one receptor, potentially amplifying results
The 12 mg dose produced the most dramatic weight loss results but also the highest incidence of adverse events
Like pancreatic -cells, the intestinal L-cells secrete PGDPs simultaneously and in equimolar concentrations
Liu S-C, Yang S-F, Yeh K-T, Yeh C-M, Chiou H-L, Lee C-Y, et al
Route, form, and dosage: Saxenda comes in a self-injectable pen
